February 13, 2018
Bensheim, Germany-based drug delivery system manufacturer Sanner GmbH and London, UK-based Amiko — a startup that has leveraged smart sensors and artificial intelligence to develop its connected inhaler and app suite Respiro — are looking to integrate novel technologies into medication packaging to better address the challenges of medication adherence.
Following an unspecified investment in the...
January 10, 2018
London-based Amiko Digital Health, which makes connected inhaler and app suite Respiro, has raised a new round of funding. The amount was not disclosed. Sanner Ventures and Breed Reply (a previous investor) led the round.
Amiko Digital Health’s flagship product, Respiro, consists of two parts. The first part is a connected inhaler for respiratory disease patients, which measures compliance, lung...